Results 131 to 140 of about 5,244 (166)

Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma. [PDF]

Front Immunol
Zong X, Yang Z, Zhou J, Jin Z, Wu D.
europepmc   +1 more source

Plasmacytosis mimicking multiple myeloma in angioimmunoblastic T-cell lymphoma: A case report and review of literature. [PDF]

World J Clin Cases
Lin CC, Lee HL, Chuo HY, Chen TA, Liu MY, Chen LM.   +5 more
europepmc   +1 more source

A case of angioimmunoblastic T-cell lymphoma presenting with migration of lung shadows. [PDF]

Respir Med Case Rep
Maruyama T, Ishiguro T, Takano K, Shimizu Y.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Angioimmunoblastic T-cell lymphoma

Critical Reviews in Oncology/Hematology, 2008
Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive neoplasm clinically characterized by sudden onset of constitutional symptoms, lymphadenopathy, hepatosplenomegaly, frequent autoimmune phenomena, particularly hemolytic anemia and thrombocytopenia, and polyclonal hypergammaglobulinemia.
Emilio Iannitto, Andres J M Ferreri, Viviana Minardi   +2 more
exaly   +6 more sources

Evaluation of cutaneous angioimmunoblastic T-cell lymphoma

Journal of the American Academy of Dermatology, 2011
Angioimmunoblastic T-cell lymphoma (AITL) accounts for 18% of peripheral T-cell lymphomas worldwide. Skin involvement occurs in up to 50% of patients but poses a diagnostic dilemma because of the limited number of reported cases and subsequent lack of established diagnostic criteria.The purpose of this review is to examine common clinical, histologic ...
Brundha, Balaraman, Jarod A, Conley, David M, Sheinbein   +2 more
exaly   +3 more sources

Angioimmunoblastic T-Cell Lymphoma

Hematology/Oncology Clinics of North America, 2017
Angioimmunoblastic T-cell lymphoma is a follicular T-helper-derived neoplasm displaying a peculiar morphologic appearance and biological complexity. New mutations have been described that contribute to elucidating the underlying pathogenetic events. The disease behaves aggressively and typically affects elderly patients.
BROCCOLI, ALESSANDRO, ZINZANI, PIER LUIGI   +1 more
  +5 more sources

Angioimmunoblastic T-Cell Lymphoma

2018
Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15-20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features.
Mariko, Yabe, Ahmet, Dogan, Steven M, Horwitz, Alison J, Moskowitz   +3 more
  +5 more sources

Angioimmunoblastic T‐cell lymphoma

British Journal of Haematology, 2003
Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T-cell lymphoma, representing about 15–20% of cases of peripheral T-cell lymphoma (PTCL). It is characterized by a unique clinical presentation and distinct pathologic and molecular features.
Ahmet, Dogan, Ayoma D, Attygalle, Chara, Kyriakou   +2 more
openaire   +3 more sources

Angioimmunoblastic T-Cell Lymphoma Management

Seminars in Hematology, 2014
Angioimmunoblastic T-cell lymphoma (AITL) is a frequent subtype of peripheral T-cell lymphoma (PTCL) that is clinically characterized by generalized lymphadenopathy, extranodal involvement, advanced stage at presentation, hypergammaglobulinemia, and significant immune dysregulation resulting in infections as the most common cause of death.
Kailash, Mosalpuria, R Gregory, Bociek, Julie M, Vose   +2 more
openaire   +2 more sources

Angioimmunoblastic T-Cell Lymphoma

2013
Angioimmunoblastic T-cell lymphoma (AITL) is a peripheral T-cell lymphoma that is associated with systemic manifestations and involves lymph nodes. The neoplasm is morphologically characterized by a polymorphous infiltrate associated with prominent high endothelial venules and follicular dendritic cell proliferation.
Benjamin J. Chen, Dick G. Hwang
  +4 more sources